Abstract
Several advances have occurred in our knowledge of the natural history and management of bronchitis. The first step has been a classification of patients with chronic bronchitis into four groups (see Table 1) (1). Chronic bronchitis is a syndrome defined by cough and production of sputum on most days for at least 3 months a year for 2 consecutive years (2). It is often complicated by airway obstruction leading to the commonly used term chronic obstructive pulmonary disease (COPD).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Wilson, R. and Wilson, C.B. (1997) Defining subsets of patients with chronic bronchitis. Chest 112, 3035–309S.
Medical Research Council (1965) Definition and classification of chronic bronchitis for clinical and epidemiological purposes. Lancet 1, 775–779.
Grossman, R.F. (1997) Guidelines for the treatment of acute exacerbations of chronic bronchitis. Chest 112, 310S–313S.
US Bureau of the Census (1994) Statistical abstract of the United States, 114th edition, US Bureau of the Census, Washington DC: p. 95.
Ball, P. (1998) Infective pathogenesis and outcomes in chronic bronchitis. Curr. Opin. Pulm. Med. 2, 161–165.
Eller, J., Ede, A., Schaberg, T., et al (1998). Infective exacerbations of chronic bronchitis. Relation between bacterial etiology and lung function. Chest 113, 1542–1548.
Saint, S., Bent, S., Vittinghoff, E., et al. (1995). Antibiotics in chronic obstructive pulmonary disease exacerbatons. JAMA 273, 957–960.
Chodosh, S., Schreurs, A., Siami, G., et al., and the Bronchitis Study Group (1998) Efficacy of oral ciprofloxacin vs. clarithromycin for treatment of acute bacterial exacerbations of chronic bronchitis. Clin. Infect. Dis. 27, 730–738.
Chodosh, S., McCarty, J., Farkas, S., et al., and the Bronchitis Study Group (1998) Randomized, double-blind study of ciprofloxacin and cefuroxime axetil for treatment of acute bacterial exacerbations of chronic bronchitis. Clin. Infect. Dis. 27, 722–729
Canadian Thoracic Society Workshop Group (1992) Guidelines for the assessment and management of chronic obstructive pulmonary disease. Can. Med. Assoc. J. 147, 420–428.
Seneff, M.G., Wagner, D.P., Wagner, R.P., et al. (1995) Hospital and 1-year survival of patients admitted to intensive care units with acute exacerbations of chronic obstructive pulmonary disease. JAMA 274, 1852–1857.
Torres, A., Dorca, J., Zalacain, R., et al. (1996) Community-acquired pneumonia in chronic obstructive pulmonary disease. A Spanish multicenter study. Am. J. Respir. Crit. Care Med. 154, 1456–1461.
Dixon, R.E. (1985) Economic costs of respiratory tract infections in the United States. Am. J. Med. 78, 45–51.
National Center for Health Statistics (1992) National hospital discharge survey: annual summary, 1990. Vital Health Stat. 13, 1–225.
Koivula, I., Stenn, M., and Makela, P.H. (1994). Risk factors for pneumonia in the elderly. Am. J. Med. 96, 313–320.
Lipsky, B.A., Boyko, E.J., Inui, T.S., et al. (1986) Risk factors for acquiring pneumococcal infections. Arch. Intern. Med. 146, 2179–2185.
Plouffe J.F., Breiman R.E., and Facklam, R.R., for the Franklin County Pneumonia Study Group. (1996) Bacteremia with Streptococcus pneumoniae. Implications for therapy and prevention. JAMA 275, 194–198.
Marston B.J, Lipman, H.B. and Breiman, R.F. (1994) Surveillance for Legionnaires’ disease. Risk factors for morbidity and mortality. Arch. Intern. Med. 154, 2417–2422.
Butler, J.C., Hofmann, J., Cretron, M.S., et al. (1996) The continued emergence of drug-resistant Streptococcus pneumoniae in the United States: an update from the Centers for Disease Control and Prevention’s surveillance system. J. Infect. Dis. 74, 986–993.
Moreno, S., Garcia-Leoni M.E., Cercenado, E., et al. (1995) Infections caused by erythromycin-resistant Streptococcus pneumoniae. Incidence, risk factors, and response to therapy in a prospective study. Clin. Infect. Dis. 20, 1195–1200.
Clavo-Sanchez, A.J., Giron-Gonzalez, J.A., Lopez-Prieto, D., et al. (1997) Multivariate analysis of risk factors for infection due to penicillin-resistant and multidrug-resistant Streptococcus pneumoniae: A multicenter study. Clin. Infect. Dis. 24, 1052–1059.
Nava, J.M., Bella, F., Garau, J., et al. (1994) Predictive factors for invasive disease due to penicillin-resistant Streptococcus pneumoniae: a population-based study. Clin. Infect. Dis.19, 884–890.
Flournoy, D.J. Stalling, F.H., and Catron, T.L. (1983) Seasonal and monthly variation of Streptococcus pneumoniae and other pathogens in bacteremia (1961–1981) Ecol. of Dis. 2 157–160.
Berendt, R.F., Long, G.G., and Walker, J.S. (1975) Influenza alone and in sequence with pneumonia due to Streptococcus pneumoniae in the squirrel monkey. J. Infect. Dis. 132, 689–693.
Berntsson, E., Lagergard, T., Strannegard, O., et al. (1986) Etiology of community-acquired pneumonia in outpatients. Europ. J. Clin. Microbiol. 5, 446–447.
Marrie, T.J, Peeling, R.W., Fine, M.J., et al. (1996) Ambulatory patients with community-acquired pneumonia. The frequency of atypical agents and clinical course. Am. J. Med. 101, 508–515.
Erard, P.H., Moser, F., Wenger, A., et al. (1991) Prospective study on community-acquired pneumonia diagnosed and followed up by private practitioner. Abstracts of the 1991 Interscience Conference on Antimicrobal Agents and Chemotherapy. Am. Soc. for Microbiol. 108, 56A.
Langille, D.B., Yates, L., and Marrie,T.J. (1993). Serological investigation of pneumonia as it presents to the physicians office. Can. J. Infect. Dis. 4, 328–332.
Porath, A., Schlaeffer, F., and Liberman, D. (1997). The epidemiology of community-acquired pneumonia among hospitalized patients. J. Infect. 34, 41–48.
Burman, L.A., Trollfors, B., Andersen, B., et al. (1993). Diagnosis of pneumonia by cultures, bacterial and viral antigen detection tests, and serology with special reference to antibodies against pneumococcal antigen. J. Infect. Dis. 163, 1087–1093.
Boht, R., van Furth, R., and van den Broek, P.J. (1995) Aetiology of community-acquired pneumonia: a prospective study among adults requiring admission to hospital. Thorax 50, 543–547.
Mundy, L.M., Aurwaeter, P.G., Oldach, D., et al. (1995) Community-acquired pneumonia: impact of immune status. Am. J. Respir. Crit. Care Med. 152, 1309–1315.
Marston, B.J. Plouffe, J.F., File, T.M., Jr., et al. (1997) Incidence of community-acquired pneumonia requiring hospitalization. Results of a population-based active surveillance study in Ohio. Arch. Intern. Med. 157 1709–1817.
Marrie, T.J., Durant, H., and Yates, L. (1989) Community-acquired pneumonia requiring hospitalization. Rev. Infect. Dis. 11, 586–599.
Kauppinen, M.T., Herva, E., Kujala, P., et al. (1995) The etiology of community-acquired pneumonia among hospitalized patients during a Chlamydia pneumoniae epidemic in Finland. J. Infect. Dis. 172, 1330–1335.
Levy, M., Dromer, F., Brion, N., et al. (1998) Community-acquired pneumonia. Importance of initial noninvasive bacteriologic and radiographic investigations. Chest 93, 43–48.
Fang, G. D., Fine, M., Orleff, J., et al. (1990) New and emerging etiologies for community-acquired pneumonia with implications for therapy. Medicine 69, 307–316.
Valenti, W.M., Trudell, R.G., and Bentley, D.W. (1978) Factors predisposing to oropharyngeal colonization with gram negative bacilli in the aged. N. Engl. J. Med. 298, 1108–1111.
Garb, J.L, Brown R.B, Garb, J., et al. (1978) Differences in etiology of pneumonias in nursing home and community patients. JAMA 240, 2169–2172
Orr, P.H., Peeling, R.W., Fast, M., et al. (1996) Serological study of responses to selected pathogens causing respiratory tract infection in the institutionalized elderly. Clin. Infect. Dis. 23, 1240–1248.
Phillips, S.L. and Branaman-Phillips, J. (1993). The use of intramuscular cefoperazone versus intramuscular ceftriaxone in patients with nursing home acquired pneumonia. J. Am. Geriatr. Soc. 41, 1071–1074.
Drinka, P.J., Gauerke, C., Voeks, S., et al. (1994) Pneumonia in a nursing home. J. Gen. Intern. Med. 9, 650–652
Chow, C.W., Senathiragah, N., Rawji, M., et al. (1994) Interim report on drug utilization review of community-acquired and nosocomial pneumonia: clinical bacteriological and radiological spectrum. Can. J. Infect. Dis. 5(Suppl. C), 20C–27C.
Marrie, T.J., Haldone, E.F., Faulkner, R.S., et al. (1985) Community-acquired pneumonia requiring hospitalization. Is it different in the elderly? J. Am. Geriatr. Soc. 33, 671–680.
Fein, A.M. (1994) Pneumonia in the elderly. Special diagnostic and therapeutic considerations. Med. Clin. North Am. 78, 1015–1033.
Granton, J.T. and Grossman, R.F. (1993) Community-acquired pneumonia in the elderly patient. Clinical features, epidemiology, and treatment. Clin. Chest. Med. 14, 537–552.
Fine, M.J., Auble, T.E., Yealy, D.M., et al. (1997) A prediction rule to identify low-risk patients with community-acquired pneumonia. N. Engl. J. Med. 336, 243–250.
Atlas, S.J., Benzer, T.I., Borowsky, L.H., et al. (1998) Safely increasing the proportion of patients with community-acquired pneumonia treated as outpatients. Arch. Intern. Med. 158, 1350–1356.
Marrie, T. Lau, C., Feagan, B., et al. (1998) A randomized controlled trial of a critical pathway for the management of community-acquired pneumonia. 6th International Quinolone Meeting, Nov. 16–18, Denver, CO.
Niederman, M.S., Best, J.B., Campbell, G.D., et al. (1993) Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity and initial antimicrobial therapy. Am. Rev. Respir. Dis. 148, 1418–1426.
Ewig, S., Ruiz, M., Mensa, J., et al. (1988) Severe community-acquired pneumonia. Assessment of severity criteria. Am. J. Respir. Crit. Care Med. 158, 1102–1108.
Ramirez, J.A., Srinath, L., Ahkee, S., et al. (1995) Early switch from intravenous to oral cephalosporins in the treatment of hospitalized patients with community-acquired pneumonia. Arch. Intern. Med. 155, 1273–1276.
Ramirez, J.A. and Ahkee, S. (1997) Early switch from intravenous antimicrobial to oral clarithromycin in patients with community-acquired pneumonia. Infect. Med. 14, 319–323.
Ramirez, J.A. (1995) Switch therapy in adult patients with pneumonia. Clin. Pulm. Med. 2, 327–333.
Meehan, T.P., Fine, M.J., Krumholz, H.M. et al. (1997) Quality of care, process and outcomes in elderly patients with pneumonia. JAMA 278, 2080.
Halm, E.A., Fine, M.J., Marrie, T.J., et al (1998) Time to clinical stability in patients hospitalized with community-acquired pneumonia. Implications for practice guidelines. JAMA 279, 1452–1457.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer Science+Business Media New York
About this chapter
Cite this chapter
Marrie, T.J. (2001). Bronchitis and Pneumonia. In: Yoshikawa, T.T., Norman, D.C. (eds) Infectious Disease in the Aging. Infectious Disease. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-026-1_6
Download citation
DOI: https://doi.org/10.1007/978-1-59259-026-1_6
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-4757-5459-9
Online ISBN: 978-1-59259-026-1
eBook Packages: Springer Book Archive